Clinical Practice Guidelines for Malignant Hyperthermia

Clinical Practice Guidelines for Malignant Hyperthermia (MH) provide healthcare professionals with standardized methods to prevent, recognize, and treat this rare, life-threatening reaction to certain anesthesia drugs. MH causes rapid increase in body temperature, muscle rigidity, and metabolic imbalance. The guidelines emphasize early diagnosis, immediate administration of specific medications like dantrolene, and supportive care such as cooling the patient. Preparedness, prompt response, and team coordination are crucial for effective management. These protocols aim to reduce complications and improve outcomes for individuals susceptible to MH when undergoing anesthesia.